Stock Events

Stock Events

Ampio Pharmaceuticals 

$0.01
46
-$0.14-93.44% Tuesday 14:14

Statistics

Day High
0.01
Day Low
0.01
52W High
0.29
52W Low
0
Volume
334
Avg. Volume
1,569
Mkt Cap
11,350
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

1AprExpected
Q2 2024
Q3 2024
Q1 2025
Q1 2025
Q2 2025
Q3 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-17.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMPE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Ampio in the development of therapies for inflammatory conditions, a key area for Ampio.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment, competes in developing drugs for similar conditions that Ampio targets, including pain management and inflammation.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the same therapeutic areas as Ampio, particularly in inflammation and immunology, making it a direct competitor.
Merck
MRK
Mkt Cap214.76B
Merck & Co. competes with Ampio in the pharmaceutical sector, focusing on innovative therapies, including treatments for inflammatory diseases.
AMGEN
AMGN
Mkt Cap160.66B
Amgen focuses on biologic medicines, including treatments for inflammatory diseases, directly competing with Ampio's product pipeline.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb offers a range of products that target inflammation and immune disorders, competing with Ampio's development focus.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is involved in the discovery, development, and commercialization of medicines in areas overlapping with Ampio's interests, including inflammatory diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in developing drugs for inflammatory conditions and other immune-related diseases, making it a competitor to Ampio.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that develops treatments for a wide range of diseases, including those related to inflammation, competing with Ampio's therapeutic focus.
Biogen
BIIB
Mkt Cap22.63B
Biogen focuses on advanced therapies for serious diseases, including inflammatory conditions, positioning it as a competitor to Ampio in the biopharmaceutical sector.

About

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.
Show more...
CEO
Mr. Michael A. Martino
Employees
6
Country
US
ISIN
US03209T3077

Listings

OTC Link
US
AMPE

0 Comments

Share your thoughts

FAQ

What is Ampio Pharmaceuticals stock price today?▼
The current price of AMPE is $0.01 USD — it has decreased by -93.44% in the past 24 hours. Watch Ampio Pharmaceuticals stock price performance more closely on the chart.
What is Ampio Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ampio Pharmaceuticals stocks are traded under the ticker AMPE.
Is Ampio Pharmaceuticals stock price growing?▼
AMPE stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Ampio Pharmaceuticals has showed a +1,566.67% increase.
What is Ampio Pharmaceuticals market cap?▼
Today Ampio Pharmaceuticals has the market capitalization of 11,350
What is Ampio Pharmaceuticals revenue for the last year?▼
Ampio Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Ampio Pharmaceuticals net income for the last year?▼
AMPE net income for the last year is -17.26M USD.
How many employees does Ampio Pharmaceuticals have?▼
As of April 01, 2026, the company has 6 employees.
In which sector is Ampio Pharmaceuticals located?▼
Ampio Pharmaceuticals operates in the Health Care sector.
When did Ampio Pharmaceuticals complete a stock split?▼
The last stock split for Ampio Pharmaceuticals was on September 12, 2023 with a ratio of 1:20.
Where is Ampio Pharmaceuticals headquartered?▼
Ampio Pharmaceuticals is headquartered in Englewood, US.